Israel Bendit is an expert in Hematology at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (Brazil). As of July 2026, ScienceLeadR ranks Israel Bendit in the top 1% of experts in Brazil for Leukemia. Israel Bendit has authored 146 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 358 (community average: 125). How the SLR is computed.

LeadR Profile

358 ScienceLeadR Reputation 358
Network Map

Hematology

Subspecialties: Oncology - Pharmacy - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026

Source: PubMed

Universidade de São Paulo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 146

Citations

Citations: 2 371 1st author: 4 Last author: 35 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
BRAFV600E mutation in high-grade dysplastic nevi: contributions to the distinction from early melanomas.
PMID 42302533 — melanoma, nevus, dermatology, mutation
An Bras Dermatol20260
Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia.
PMID 40339533 — genes, cytochrome p-450 enzyme system, transferases, cytochromes, neutrophils, leukemia, recycling, leukemia, myeloid, acute, leukemia, myeloid, genetic profile, glutathione
Hematol Transfus Cell Ther20250
Novel variants of the ATRX gene identified in MYCN non-amplified Neuroblastoma in Brazilian patients.
PMID 40286729 — genes, neoplasms, mutation, neuroblastoma, prognosis, child
Clinics (Sao Paulo)20250
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
PMID 39615869 — cells, precursor cell lymphoblastic leukemia-lymphoma, phenotype, leukemia, pharmacology, therapeutics, cell cycle, ezrin
Eur J Pharmacol20241
Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients.
PMID 39691248 — genes, precursor cell lymphoblastic leukemia-lymphoma, leukemia
EJHaem20241

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 3 1

By status:

Completed 1
Unknown 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map